Cargando…
P537: SAFETY AND TOLERABILITY OF AZD0466 AS MONOTHERAPY FOR PATIENTS WITH ADVANCED HEMATOLOGICAL MALIGNANCIES - PRELIMINARY RESULTS FROM AN ONGOING PHASE I/II TRIAL
Autores principales: | Marconi, Giovanni, Arslan, Shukaib, Fleming, Shaun, Curti, Antonio, S Blachly, James, Martinelli, Giovanni, Giovanni Della Porta, Matteo, Bajel, Ashish, Sauer, Tim, Crysandt, Martina, Pigneux, Arnaud, Konopleva, Marina, Marmor, Yotvat, Sharma, Shringi, Elgeioushi, Nairouz, Rowe, Emily, Cheung, Patricia, Jahn, Ekaterina, Saeh, Jamal, Tibes, Raoul, Zumla Cader, Fathima, Jain, Nitin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429176/ http://dx.doi.org/10.1097/01.HS9.0000969056.80196.f1 |
Ejemplares similares
-
Design and optimisation of dendrimer-conjugated Bcl-2/x(L) inhibitor, AZD0466, with improved therapeutic index for cancer therapy
por: Patterson, Claire M., et al.
Publicado: (2021) -
P579: SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PRELIMINARY ANTITUMOR ACTIVITY OF AZD5991 IN RELAPSED/ REFRACTORY HEMATOLOGIC MALIGNANCIES: A PHASE 1 FIRST-IN-HUMAN STUDY
por: Desai, Pinkal, et al.
Publicado: (2023) -
A novel BH3-mimetic, AZD0466, targeting BCL-XL and BCL-2 is effective in pre-clinical models of malignant pleural mesothelioma
por: Arulananda, Surein, et al.
Publicado: (2021) -
P04.66 Comparing attitudes preceding and succeeding complementary and alternative medicine and integrative medicine undergraduate courses
por: Reeves, A, et al.
Publicado: (2012) -
Piano sonatas D. 664, D. 537
por: Schubert, Franz, 1797-1828
Publicado: (1994)